phosphodiesterase 2A, CGMP-Stimulated (PDE2A) Peptide
-
- Target See all PDE2A products
- PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- CRSQQYPAAR PAEPRGQQVF LKPDEPPPQP CADSLQDALL SLGAVIDIAG
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of Pde2 a antibody,
Alternative Names: Pde2a control peptide, Pde2a antibody Blocking Peptide, Anti-Pde2a Blocking Peptide, phosphodiesterase 2A, cGMP-stimulated Blocking Peptide, Pde2 Blocking Peptide, Pde2a2 Blocking Peptide, Pde2a Blocking Peptide, Pde2a, Pdea-2, Pdea 2, Pdea-2 Blocking Peptide, Pdea 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
- Synonyms
- PDE2A Peptide, CGS-PDE Peptide, PDE2A1 Peptide, PED2A4 Peptide, cGSPDE Peptide, Pde2 Peptide, Pde2a2 Peptide, phosphodiesterase 2A Peptide, phosphodiesterase 2A, cGMP-stimulated Peptide, PDE2A Peptide, pde2a Peptide, Pde2a Peptide
- Background
- The activation of Pde2a induces decreased cAMP accumulation, It is involved in nitric oxide mediated signaling in cardiac fibroblasts.
- Molecular Weight
- 104 kDa
-